HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Steven Oberste Selected Research

Poliomyelitis (Polio)

6/2022Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
1/2021Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial.
1/2021Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama.
1/2021A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania.
1/2021Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
1/2021Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain.
1/2021Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
11/2020Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.
11/2019Pan-viral serology implicates enteroviruses in acute flaccid myelitis.
10/2019Poliopolis: pushing boundaries of scientific innovations for disease eradication.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Steven Oberste Research Topics

Disease

54Poliomyelitis (Polio)
06/2022 - 04/2002
15Infections
01/2020 - 03/2008
6acute flaccid myelitis
06/2022 - 01/2016
3Malnutrition (Nutritional Deficiencies)
01/2018 - 01/2014
3Asthma (Bronchial Asthma)
11/2016 - 09/2015
2Encephalitis (Encephalitis, Rasmussen)
01/2020 - 03/2013
2Meningitis
01/2020 - 02/2011
2Seizures (Absence Seizure)
01/2020 - 05/2018
2Diarrhea
08/2017 - 01/2014
2Human Influenza (Influenza)
11/2016 - 03/2013
2Virus Diseases (Viral Diseases)
09/2015 - 03/2011
2Enterovirus Infections
08/2015 - 11/2013
2Exanthema (Rash)
07/2015 - 03/2013
2Myocarditis (Carditis)
09/2009 - 09/2007
1Hypersensitivity (Allergy)
01/2021
1Gastroenteritis
11/2019
1Central Nervous System Diseases (CNS Diseases)
01/2019
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2019
1Neurologic Manifestations (Neurological Manifestations)
05/2018
1Pneumonia (Pneumonitis)
01/2018
1Growth Disorders
09/2017
1Shock
11/2016
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2016
1Vaccine-Preventable Diseases
01/2016
1Intussusception
11/2015
1Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease)
07/2015
1Chickenpox
07/2015
1Sepsis (Septicemia)
01/2015
1Inflammation (Inflammations)
08/2014
1Mumps
12/2013
1Dengue (Dengue Fever)
03/2013
1Hemorrhage
03/2013
1Malaria
01/2012
1Chest Pain (Chest Pains)
01/2012
1Cough
01/2012
1Paralysis (Palsy)
01/2011
1Left Ventricular Dysfunction
09/2009
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
02/2009
1Neonatal Sepsis
03/2008

Drug/Important Bio-Agent (IBA)

44VaccinesIBA
06/2022 - 04/2002
11Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link
01/2022 - 11/2013
11Oral Poliovirus Vaccine (Sabin Vaccine)IBA
01/2021 - 04/2013
10AntibodiesIBA
11/2019 - 01/2014
7Neutralizing AntibodiesIBA
01/2021 - 01/2011
7Antiviral Agents (Antivirals)IBA
01/2020 - 03/2008
6Poliovirus VaccinesIBA
01/2021 - 01/2016
4Immunoglobulin A (IgA)IBA
01/2018 - 01/2014
3RNA (Ribonucleic Acid)IBA
11/2019 - 03/2008
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2015 - 02/2011
3EnzymesIBA
01/2014 - 03/2008
3Nucleic AcidsIBA
02/2011 - 09/2008
2Biological ProductsIBA
01/2020 - 11/2013
2Peptides (Polypeptides)IBA
11/2019 - 01/2019
2Intravenous Immunoglobulins (IVIG)FDA Link
12/2018 - 08/2015
2AntigensIBA
01/2018 - 01/2012
2pocapavirIBA
02/2017 - 01/2015
2Immunoglobulin M (IgM)IBA
01/2016 - 12/2013
1Fibroins (Fibroin)IBA
11/2020
1Rotavirus VaccinesIBA
11/2019
1Disinfectants (Biocides)IBA
12/2018
1Acyclovir (Aciclovir)FDA LinkGeneric
05/2018
1Albuterol (Salbutamol)FDA LinkGeneric
11/2016
1SteroidsIBA
11/2016
1varicella-zoster immune globulin (VZIG)IBA
07/2015
1CytokinesIBA
08/2014
1Glucagon (Glukagon)FDA Link
08/2014
1Insulin (Novolin)FDA Link
08/2014
1SuspensionsIBA
05/2014
1Capsid Proteins (Capsid Protein)IBA
05/2014
1ImmunosorbentsIBA
01/2014
1LipidsIBA
11/2011
1Polysaccharides (Glycans)IBA
11/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2011
1Anti-Bacterial Agents (Antibiotics)IBA
11/2011
1Interferon Type IIBA
03/2011
1Pattern Recognition ReceptorsIBA
03/2011
1Immune Sera (Antisera)IBA
01/2011
1N-Acetylneuraminic Acid (Sialic Acid)IBA
03/2008
1LectinsIBA
03/2008
1ParaffinIBA
09/2007

Therapy/Procedure

3Therapeutics
09/2015 - 01/2015
1Intradermal Injections
01/2019
1Ambulatory Care (Outpatient Care)
08/2017
1Length of Stay
11/2016
1Mechanical Ventilators (Ventilator)
11/2015
1Critical Care (Surgical Intensive Care)
11/2015
1Respiratory Therapy (Therapy, Respiratory)
09/2015
1Tourniquets
03/2013
1Heart Transplantation (Grafting, Heart)
09/2009